Minerals Technologies (MTX)
NYSEMaterialsChemicals - SpecialtySnapshot 2026-09-04
$71.76+1.28%
Close 2026-09-04 · 1-day change
NYSEMaterialsChemicals - SpecialtySnapshot 2026-09-04
QuarterlyIQ Insights · MTX
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 11 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $72 MTX trades at 12× p/e, below its 17× p/e peer median. Our $94 fair value sits well above the price. It's a high-confidence read. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| dcf fcfe | 12M | $133.30 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $250.69 | — | — | Hist. CAGR | high |
| graham number | 12M | $81.34 | — | — | TTM | high |
| Peer EV/EBITDA | 12M | $81.50 | 10.0 | 10.13 | TTM | high |
| Peer P/FCF | 12M |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Around the middle on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
No fragility gates fired. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks cheaper than most peers in the same business.
Around its own typical valuation.
Trailing four: 2025-Q2, 2025-Q3, 2026-Q1, 2026-Q2
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| $81.55 |
| 21.1 |
| 3.87 |
| TTM |
| high |
| Peer P/E | 12M | $100.66 | 17.4 | 5.80 | TTM | high |
| Peer P/S | 12M | $100.04 | 1.4 | 69.04 | TTM | high |
| PEG | 12M | $141.49 | 24.4 | 5.80 | TTM | high |
| residual income | 12M | $56.61 | — | — | TTM | high |
| Own P/E history | 12M | $74.97 | 12.9 | 5.80 | TTM | high |
| triangulated | 12M | $103.59 | 17.4 | 5.97 | Triangulated | high |
| Peer P/FCF | 3Y | $124.02 | 21.1 | 5.88 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $132.18 | 17.4 | 7.62 | Analyst | medium |
| Peer P/S | 3Y | $115.93 | 1.4 | 80.01 | Analyst | medium |
| PEG | 3Y | $185.78 | 24.4 | 7.62 | Analyst | medium |
| Own P/E history | 3Y | $98.44 | 12.9 | 7.62 | Analyst | medium |
| Peer P/FCF | 5Y | $164.02 | 21.1 | 7.78 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $145.49 | 17.4 | 8.38 | Analyst | high |
| Peer P/S | 5Y | $127.61 | 1.4 | 88.07 | Analyst | high |
| PEG | 5Y | $204.49 | 24.4 | 8.38 | Analyst | high |
| Own P/E history | 5Y | $108.36 | 12.9 | 8.38 | Analyst | high |